Telemedicine in the Era of COVID-19: Mitigating Risk for People Living with Multiple Sclerosis

RELEASE DATE: July 31, 2020

EXPIRATION DATE: July 31, 2021

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Nurses — 1.5 Contact Hours
  • Pharmacists – 1.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for neurology and primary care physicians, nurse practitioners, PAs, nurses, pharmacists, rehabilitation specialists, mental health professionals, and other members of the healthcare team essential to the care of patients living with MS.

Learning Objectives

  • Review the history of and current known facts related to COVID-19
  • Describe the risks of COVID-19 in people living with MS
  • Discuss opportunities for care and best practices for implementation of telemedicine for people living with MS
  • Employ best practices for implementation of telemedicine in MS management


Edward J. Fox, MD, PhD (Chairperson)
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor, University of Texas Dell Medical School

Stephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCN
Director of Clinical Services
Multiple Sclerosis Clinic of Central Texas

Joseph R. Berger, MD, FACP, FAAN, FANA
Professor of Neurology and Associate Chief of the MS Division
Perelman School of Medicine
University of Pennsylvania

Frederick W. Foley, PhD
Professor of Psychology, Yeshiva University, Ferkauf Graduate School of Psychology
Director of Neuropsychology and Psychosocial Research, Holy Name Medical Center Multiple Sclerosis Center

Supported by an educational grant from Novartis Pharmaceuticals Corporation.